X @Litecoin

Litecoin Adoption - MEI Pharma purchased $100 million of Litecoin (LTC) as a treasury asset [1] - MEI Pharma is the first U S-listed company to adopt Litecoin as a primary treasury asset [2] - The purchase was funded via a $100 million private placement led by Charlie Lee [2] Rationale for Adoption - MEI Pharma cites Litecoin's 13-year uptime, low fees, fast settlement, and mainstream integrations as reasons for adoption [2] Future Plans - MEI Pharma may expand into LTC mining [2] Company Strategy - MEI Pharma continues drug development while pioneering a crypto treasury strategy [2]